Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients Pending

2023-504846-73-01 Glioblstoma WHO grade IV 4
CLINICAL TRIAL FOR THE PREVENTION OF CYTOMEGALOVIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH NO AVAILABLE TREA… Pending

2024-520020-28-00 Cytomegalovirus infection post allogeneic allogeneic HL 7
DORAL Pending

2024-513941-35-00 HIV Disease 9
Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN) Pending

2024-520042-31-00 HSV-2 meningitis 6
Randomized, double-blind, phase 2 clinical trial controlled with conventional Bacillus Calmette-Guérin (BCG) vaccine to evaluate the safety … Pending

2023-509048-80-01 The present Phase 2 clinical study will evaluate the sa 4
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Pending

2024-511054-50-00 HIV-1 Infection 10
PLUTO Pending

2026-525211-14-00 HIV-1 4
PALETTE - Trial for personalisation of sepsis treatment in children and adults Pending

2025-521371-31-00 Sepsis 4
IMPACT-NAC: A clinical trial of N-acetylcysteine for adults with severe infection and liver dysfunction Pending

2026-525895-25-00 Acute infection 6
RISE Pending

2024-520141-23-01 RSV infection 5
Temporal kinetics of antibody and cellular response markers and relative impact of revaccination in patients recovered from COVID-19 after t… Pending

2024-514071-17-00 Covid-19 infection 6
A Study of the Safety, Tolerability, PK, PD, and Efficacy of CRMA-1001 in Chronic Hepatitis B Recruiting

2025-523619-12-00 Chronic Hepatitis B 7 2026-05-22
A phase 2, multicentric study to assess the efficacy and safety of maribavir treatment in hematopoietic stem cell transplant (HSCT) recipien… Recruiting

2025-521074-34-00 Allogeneic peripheral hematopoietic stem cell transplan 4 2026-05-15
Single-centre clinical trial investigating the safety and tolerability of increasing multiple doses of nebulised SS0331 in healthy participa… Recruiting

2025-523530-30-00 Treatment and post exposure prevention of respiratory t 1 2026-05-11
Efficacy and safety study of intravenous brincidofovir compared to intravenous cidofovir for the treatment of adenovirus infection in childr… Recruiting

2025-521903-28-00 Adenovirus viremia 5 2026-05-06
A first in human study of people with chronic hepatitis B, where all participants will receive the new drug PBGENE-HBV. This study will use … Recruiting

2025-524157-13-00 Chronic Hepatitis B 1 2026-04-28
A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study) Recruiting

2025-522125-36-00 Chronic hepatitis D infection 3 2026-04-22
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus. Recruiting

2025-522729-36-00 Chronic Hepatitis Delta. 7 2026-03-11
A study on the immune response and safety of an investigational chickenpox vaccine and a marketed measles, mumps and rubella vaccine when ad… Recruiting

2024-518840-18-00 Varicella 5 2025-12-10
A Phase III Randomised, Open Label Trial of an Intradermal or Subcutaneous booster dose of MVA-BN Vaccine to Investigate MPXV Immunogenicity… Recruiting

2024-518007-22-00 Prevention of monkeypox (mpox) infection 5 2025-12-05
Phase 3 trial of eRapa in patients with familial adenomatous polyposis (FAP) Recruiting

2025-522946-37-00 Familial adenomatous polyposis (FAP) 5 2025-11-24
A study evaluating persistence of the immune response of the adjuvanted RSV vaccine and the safety and immunogenicity following revaccinatio… Recruiting

2024-519730-23-00 Respiratory Syncytial Virus Infections 4 2025-11-10
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy Recruiting

2023-510022-33-00 HIV-1 infection 5 2024-10-02
A Phase 2/3 Safety, Pharmacokinetics, and Efficacy Study ofNirmatrelvir/Ritonavir in Pediatric, Nonhospitalized Symptomatic Participants Wit… Recruiting

2023-509773-23-00 SARS-CoV-2 Infection 10 2023-07-13